ENVALITH
武田薬品工業株式会社 logo

Takeda Pharmaceutical Company Limited

4502Prime MarketPharmaceuticals

武田薬品工業株式会社 logo
Takeda Pharmaceutical Company Limited4502

Governance

Company with an Audit and Supervisory Committee. Of the 14 directors, 11 are outside directors (outside director ratio of approximately 79%), and the chairman of the Board of Directors is an independent outside director. The Audit and Supervisory Committee is composed entirely of outside directors. Both the Nomination Committee and Compensation Committee are voluntary advisory bodies whose members are all outside directors, reflecting a highly transparent and independent governance structure.

Outside Director Ratio

78.6%

Nomination Committee

Established

Compensation Committee

Established

Risk Management

Enterprise-wide risk management, business continuity management, and crisis management are operated in an integrated manner based on the

Shareholder Returns

Continuation of progressive dividend policy. Annual dividend for FY2025 is ¥200 per share (interim ¥100, year-end ¥100), with FY2026 forecast at ¥204. Share buybacks are conducted when appropriate. Financial target is an adjusted net interest-bearing debt/adjusted EBITDA ratio of 2x.

Dividend Policy

Adopts a progressive dividend policy aiming to increase or maintain the annual dividend per share each year. The annual dividend for FY2025 is ¥200 per share (interim dividend ¥100, year-end dividend ¥100). The annual dividend forecast for FY2026 is ¥204 per share. Dividends are paid twice a year, as interim and year-end dividends. With respect to share repurchases, the policy is to undertake them when appropriate. The company aims to maintain a solid investment-grade credit rating, targeting an adjusted net interest-bearing debt/adjusted EBITDA ratio of 2x.

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

The company advances ESG activities around three pillars: Patient (improving access and ensuring stable supply), People (enhancing employee engagement and developing digital skills), and Planet (SBTi-certified greenhouse gas reduction targets: net zero for Scope 1 and 2 by FY2035 and net zero for Scope 3 by FY2040). In FY2025, Scope 1 and 2 emissions achieved a 58% reduction versus FY2016, and the employee engagement score improved to 79 (up from 76 in the prior year). Third-party limited assurance has been obtained from KPMG AZSA Sustainability Co., Ltd.

Last updated: June 17, 2026